What are the symptoms of parvovirus infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parvovirus B19 Infection: Clinical Manifestations

Parvovirus B19 infection presents most commonly as erythema infectiosum ("fifth disease") in children with the characteristic "slapped-cheek" rash, though many infected individuals remain asymptomatic or develop only mild cold-like symptoms. 1

Primary Clinical Presentations by Population

In Healthy Children

  • Classic "slapped-cheek" rash (erythema infectiosum) is the hallmark presentation, appearing as bright red facial erythema 1, 2
  • By the time the rash appears, the patient is no longer infectious 1
  • Mild, nonspecific cold-like symptoms may precede or accompany the rash 1
  • The infection is self-limited, resolving within 1-2 weeks 3, 4

In Adults

  • Polyarthralgias and joint involvement are the most common manifestations, occurring in 65% of cases 3
  • Joint symptoms can present as acute or persistent arthropathy 1
  • Generalized maculopapular rash with fever occurs frequently 3
  • "Gloves and socks" syndrome: papular, purpuric eruptions on hands and feet, seen in 6.5% of cases 3, 1
  • Other skin manifestations include periflexural rash (4%) and edema (4%) 3
  • Women are affected more than men (ratio 2.2:1), with mean age of 41 years 3

High-Risk Populations and Severe Manifestations

Patients with Hemolytic Disorders

  • Transient aplastic crisis (TAC) is the critical complication in patients with underlying hemolytic conditions 4, 1, 2
  • The virus has affinity for red blood cell precursors, causing temporary cessation of bone marrow RBC production 4
  • This is particularly dangerous in patients with sickle cell disease, hereditary spherocytosis, thalassemia, or iron deficiency anemia 1, 2
  • Substantially decreased reticulocyte count (typically below 1%) with worsening anemia indicates TAC 5
  • Severe life-threatening anemia may require urgent blood transfusions 4
  • Siblings or other contacts with sickle cell disease are at risk for concurrent or subsequent aplastic crisis 5

Immunocompromised Patients

  • Persistent infection may develop, presenting as pure red cell aplasia and chronic anemia 2
  • Treatment may require intravenous immune globulin therapy 1

Pregnant Women

  • Non-immune pregnant women risk fetal infection, with greater complications in first or second trimester 6
  • Fetal complications include severe anemia, hydrops fetalis, congenital anemia, or pregnancy loss 6, 2
  • Most infected fetuses show no abnormalities 6
  • Maternal symptoms include fever, rash, and joint pain if symptomatic 6

Hematological Manifestations

  • Anemia is the main hematological alteration, occurring in 35% of acute infections 3
  • Transient aplastic crisis represents acute cessation of red blood cell production 1, 2
  • Chronic red cell aplasia can occur in immunosuppressed patients 1

Transmission and Infectivity

  • Spreads mainly through respiratory droplets, making it highly infectious 1
  • Also transmitted by hand-to-mouth contact, blood transfusion, or transplacental transmission 6
  • Common in daycares and professions requiring close contact with children 4
  • Critical pitfall: Patients are no longer infectious once the rash appears, but are highly contagious during the prodromal phase 1

Clinical Course

  • Symptoms are typically self-limiting and resolve in 1-2 weeks in most immunocompetent patients 3, 4
  • Treatment is usually supportive 1
  • Some patients may require transfusions or intravenous immune globulin therapy, particularly those with aplastic crisis or immunocompromise 1
  • Most patients recover completely 1

References

Research

Clinical presentations of parvovirus B19 infection.

American family physician, 2007

Research

Parvovirus B19 in human disease.

Annual review of medicine, 1997

Guideline

Reticulocyte Count Utility in Sickle Cell Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.